Start an analysis for DGX
Quest Diagnostics Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $15.0bn | 30-Sep-26 | 10-Q filed 23-Oct-26 |
| Remaining authorization | $1.2bn | 30-Sep-26 | 10-Q filed 23-Oct-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $150m | 30-Sep-26 | 10-Q filed 23-Oct-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $1.0bn | $1.0bnEST | n/a | In February 2026, our Board of Directors increased the size of our share repurchase program by $1 billion.10-Q filed 23-Oct-26 |
| Not found in filings | $14.0bn | $183mEST | n/a | Since the share repurchase program’s inception in May 2003, our Board of Directors has authorized $14 billion of share repurchases of our common stock through September 30, 2026. The share repurchase authorization has no set expiration or termination date.10-Q filed 23-Oct-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Withheld & other | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|
| 30-Sep-26 | 627,674 | — | $238.98 | $150m | 10-Q filed 23-Oct-26 |
| 31-Aug-26 | 0 | — | — | $0 | 10-Q filed 23-Oct-26 |
| 31-Jul-26 | 0 | — | — | $0 | 10-Q filed 23-Oct-26 |
| 30-Jun-26 | 0 | — | — | $0 | 10-Q filed 23-Jul-26 |